Cargando…

Chronic Hepatitis C Virus Infection: An Ongoing Challenge in Screening and Treatment

With the advent of direct-acting antiviral agents (DAA) in the recent few years, hepatitis C virus (HCV) infection has become a curable infectious disease. Successful clearance of HCV could lead to improvement of both hepatic and extrahepatic outcomes, such as complications of cirrhosis, hepatocellu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Wei-Chu, Chiang, Hseuh-Chien, Chiu, Yen-Cheng, Chien, Shih-Chieh, Cheng, Pin-Nan, Chiu, Hung-Chih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608250/ https://www.ncbi.nlm.nih.gov/pubmed/37895346 http://dx.doi.org/10.3390/life13101964

Ejemplares similares

The characteristics of residents with unawareness of hepatitis C virus infection in community
por: Cheng, Pin-Nan, et al.
Publicado: (2018)

The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program
por: Cheng, Pin-Nan, et al.
Publicado: (2016)

Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection
por: Chien, Shih-Chieh, et al.
Publicado: (2022)

Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss
por: Wu, I-Chin, et al.
Publicado: (2021)

Comparison of FIB-4 and transient elastography in evaluating liver fibrosis of chronic hepatitis C subjects in community
por: Cheng, Pin-Nan, et al.
Publicado: (2018)

Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy
por: Lin, Tien-Ching, et al.
Publicado: (2018)

Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients
por: Cheng, Pin-Nan, et al.
Publicado: (2019)

Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment
por: Chiu, Shao-Ming, et al.
Publicado: (2020)

Molecular Identification and Selection of Probiotic Strains Able to Reduce the Serum TMAO Level in Mice Challenged with Choline
por: Ramireddy, Latha, et al.
Publicado: (2021)

Hepatitis C Virus Non-Structural Protein 3 Interacts with Cytosolic 5′(3′)-Deoxyribonucleotidase and Partially Inhibits Its Activity
por: Fang, Chiu-Ping, et al.
Publicado: (2013)

Kinome-Wide siRNA Screening Identifies DYRK1B as a Potential Therapeutic Target for Triple-Negative Breast Cancer Cells
por: Chang, Chia-Che, et al.
Publicado: (2021)

Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
por: Tsai, Hong-Ming, et al.
Publicado: (2021)

Functional roles of pluripotency transcription factors in mesenchymal stem cells
por: Tsai, Chih-Chien, et al.
Publicado: (2012)

From Bench to Bedside: Clinical and Biomedical Investigations on Hepatitis C Virus (HCV) Genotypes and Risk Factors for Albuminuria
por: Hsiao, Po-Jen, et al.
Publicado: (2022)

Ongoing challenges in implementation of lung cancer screening
por: Martini, Katharina, et al.
Publicado: (2021)

Trajectories of Health Changes in Older Adults with Chronic Hepatitis B Infection
por: Wu, I-Chien, et al.
Publicado: (2020)

Highly Sensitive Luminescent Bioassay Using Recombinant Escherichia coli Biosensor for Rapid Detection of Low Cr(VI) Concentration in Environmental Water
por: Wang, Guey-Horng, et al.
Publicado: (2021)

Association between IPTA Gene Polymorphisms and Hematological Abnormalities in Hepatitis C Virus-Infected Patients Receiving Combination Therapy
por: Hwang, Jow-Jyh, et al.
Publicado: (2015)

Conception of a Smart Artificial Retina Based on a Dual‐Mode Organic Sensing Inverter
por: Hung, Chih‐Chien, et al.
Publicado: (2021)

Microelimination of Chronic Hepatitis C by Universal Screening Plus Direct-Acting Antivirals for Incarcerated Persons in Taiwan
por: Yang, Tsung-Hua, et al.
Publicado: (2020)

Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C
por: Lin, Sheng Feng, et al.
Publicado: (2020)

Biofunctional Activities of Equisetum ramosissimum Extract: Protective Effects against Oxidation, Melanoma, and Melanogenesis
por: Li, Pin-Hui, et al.
Publicado: (2016)

Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan
por: Chen, Chi‐Yi, et al.
Publicado: (2021)

Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
por: Yang, Chi-Chieh, et al.
Publicado: (2015)

Insulin Resistance Associated Disorders Pivoting Long-Term Hepatitis B Surface Antigen Decline During Entecavir Therapy
por: Lin, Tien-Ching, et al.
Publicado: (2019)

Serum Fetuin A and Chemerin Levels Correlate with Hepatic Steatosis and Regional Adiposity in Maintenance Hemodialysis Patients
por: Chen, Hung-Yuan, et al.
Publicado: (2012)

Seroprevalence of Hepatitis B Virus among Adults at High Risk for HIV Transmission Two Decades after Implementation of Nationwide Hepatitis B Virus Vaccination Program in Taiwan
por: Sun, Hsin-Yun, et al.
Publicado: (2014)

Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications – A National Population-Based Cohort Study
por: Chiu, Hsien-Yi, et al.
Publicado: (2015)

State-of-the-Art Chronic Hepatitis Viruses Research in Asia
por: Chien, Rong-Nan
Publicado: (2023)

Risk of Non-Hodgkin Lymphoma among Patients with Hepatitis B Virus and Hepatitis C Virus in Taiwan: A Nationwide Cohort Study
por: Lai, Yung-Rung, et al.
Publicado: (2022)

Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C
por: Huang, Chao-Min, et al.
Publicado: (2017)

Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH)
por: Tsai, Pei-Chien, et al.
Publicado: (2020)

Hepatitis B Virus X Protein Upregulates mTOR Signaling through IKKβ to Increase Cell Proliferation and VEGF Production in Hepatocellular Carcinoma
por: Yen, Chia-Jui, et al.
Publicado: (2012)

Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
por: Hsu, Wei-Fan, et al.
Publicado: (2020)

Combating biothreat pathogens: ongoing efforts for countermeasure development and unique challenges
por: Duplantier, Allen J., et al.
Publicado: (2020)

Circulating gut microbiota-related metabolites influence endothelium plaque lesion formation in ApoE knockout rats
por: Chuang, Hsiao-Li, et al.
Publicado: (2022)

Newly-diagnosed immunoglobulin A nephropathy with increased plasma galactose-deficient-IgA(1) antibody associated with mRNA COVID-19 vaccination: a case report
por: Chen, Yun-Sung, et al.
Publicado: (2022)

Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma
por: Tsai, Hung-Wen, et al.
Publicado: (2016)

Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial
por: Yu, Chih-Chieh, et al.
Publicado: (2012)

Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
por: Cheng, Pin-Nan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dhbit5afk4v83cf63upj8qqddk